Ken Frazier addresses the complexities of our healthcare system and drug pricing with the U.S. Senate Committee on Finance. Read our statement httpsbit.ly2ExYMYrÂpic.twitter.comDcGINd2ySH

Ken Frazier addresses the complexities of our healthcare system and drug pricing with the U.S. Senate Committee on Finance. Read our statement: https://bit.ly/2ExYMYr pic.twitter.com/DcGINd2ySH

11:29 EST 26 Feb 2019 | Merck & Co., Inc.

Ken Frazier addresses the complexities of our healthcare system and drug pricing with the U.S. Senate Committee on Finance. Read our statement: https://bit.ly/2ExYMYr  pic.twitter.com/DcGINd2ySH

More From BioPortfolio on "Ken Frazier addresses the complexities of our healthcare system and drug pricing with the U.S. Senate Committee on Finance. Read our statement: https://bit.ly/2ExYMYr pic.twitter.com/DcGINd2ySH"